Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis

László Romics, Elemér Nemesánszky, F. Szalay, A. Császár, Judit Tresch, I. Karádi

Research output: Article

5 Citations (Scopus)

Abstract

We studied a selected group of 39 female patients suffering from primary biliary cirrhosis (PBC). This disease is characterized by typical lipoprotein alterations and elevated concentrations of serum cholesterol. Despite the increased concentration of atherogenic lipoproteins, enhanced atherogenesis is not characteristic of PBC. Serum total cholesterol, triglycerides, HDL2 and HDL3-cholesterol concentrations were measured by enzymatic methods or in combination with precipitation procedures. Apolipoproteins were determined by using immunonephelometric methods. ELISA sandwich method was used for lipoprotein(a) determinations. Apoprotein(a) phenotyping (isoforms) was performed by Western blotting with specific antibodies. The concentrations of serum lipids, lipoproteins and apoproteins (AI, AII and B) were found in the range of earlier investigations. The serum lipoprotein(a) concentration did not differ between the PBC patients and control subjects (10.0/0.1- 54/, median 2.55 vs. 11.5/0-75/, median 5.2 mg/dl). In the advanced stages of PBC we found a higher number of patients with low lipoprotein concentration (lower than 1 mg/dl). In patients with shorter durations and milder histological alterations high HDL2 cholesterol subfractions has been detected (stage I = 0.42 ± 0.18, stage II = 0.53 ± 0.29 and stage III = 0.62 ± 0.41 vs. stage IV = 0.26 ± 0.15 mmol/l, P <0.05). Despite the elevation of atherogenic lipoproteins, high HDL2-cholesterol and normal lipoprotein(a) concentrations may be one of the reasons why patients with advanced PBC are not placed at increased risk for atherosclerosis.

Original languageEnglish
Pages (from-to)165-171
Number of pages7
JournalClinica Chimica Acta
Volume255
Issue number2
DOIs
Publication statusPublished - nov. 29 1996

Fingerprint

Lipoprotein(a)
Biliary Liver Cirrhosis
Lipoproteins
HDL Cholesterol
Phenotype
Serum
Atherosclerosis
Cholesterol
Apoprotein(a)
Apoproteins
Apolipoproteins
Apolipoproteins B
Protein Isoforms
Triglycerides
Western Blotting
Enzyme-Linked Immunosorbent Assay
Lipids
Antibodies

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis. / Romics, László; Nemesánszky, Elemér; Szalay, F.; Császár, A.; Tresch, Judit; Karádi, I.

In: Clinica Chimica Acta, Vol. 255, No. 2, 29.11.1996, p. 165-171.

Research output: Article

Romics, László ; Nemesánszky, Elemér ; Szalay, F. ; Császár, A. ; Tresch, Judit ; Karádi, I. / Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis. In: Clinica Chimica Acta. 1996 ; Vol. 255, No. 2. pp. 165-171.
@article{55c747897f3d4fea9c479310c345a4a4,
title = "Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis",
abstract = "We studied a selected group of 39 female patients suffering from primary biliary cirrhosis (PBC). This disease is characterized by typical lipoprotein alterations and elevated concentrations of serum cholesterol. Despite the increased concentration of atherogenic lipoproteins, enhanced atherogenesis is not characteristic of PBC. Serum total cholesterol, triglycerides, HDL2 and HDL3-cholesterol concentrations were measured by enzymatic methods or in combination with precipitation procedures. Apolipoproteins were determined by using immunonephelometric methods. ELISA sandwich method was used for lipoprotein(a) determinations. Apoprotein(a) phenotyping (isoforms) was performed by Western blotting with specific antibodies. The concentrations of serum lipids, lipoproteins and apoproteins (AI, AII and B) were found in the range of earlier investigations. The serum lipoprotein(a) concentration did not differ between the PBC patients and control subjects (10.0/0.1- 54/, median 2.55 vs. 11.5/0-75/, median 5.2 mg/dl). In the advanced stages of PBC we found a higher number of patients with low lipoprotein concentration (lower than 1 mg/dl). In patients with shorter durations and milder histological alterations high HDL2 cholesterol subfractions has been detected (stage I = 0.42 ± 0.18, stage II = 0.53 ± 0.29 and stage III = 0.62 ± 0.41 vs. stage IV = 0.26 ± 0.15 mmol/l, P <0.05). Despite the elevation of atherogenic lipoproteins, high HDL2-cholesterol and normal lipoprotein(a) concentrations may be one of the reasons why patients with advanced PBC are not placed at increased risk for atherosclerosis.",
keywords = "Atherosclerosis, Lipoprotein(a), Lipoproteins, Primary biliary cirrhosis",
author = "L{\'a}szl{\'o} Romics and Elem{\'e}r Nemes{\'a}nszky and F. Szalay and A. Cs{\'a}sz{\'a}r and Judit Tresch and I. Kar{\'a}di",
year = "1996",
month = "11",
day = "29",
doi = "10.1016/0009-8981(96)06404-2",
language = "English",
volume = "255",
pages = "165--171",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis

AU - Romics, László

AU - Nemesánszky, Elemér

AU - Szalay, F.

AU - Császár, A.

AU - Tresch, Judit

AU - Karádi, I.

PY - 1996/11/29

Y1 - 1996/11/29

N2 - We studied a selected group of 39 female patients suffering from primary biliary cirrhosis (PBC). This disease is characterized by typical lipoprotein alterations and elevated concentrations of serum cholesterol. Despite the increased concentration of atherogenic lipoproteins, enhanced atherogenesis is not characteristic of PBC. Serum total cholesterol, triglycerides, HDL2 and HDL3-cholesterol concentrations were measured by enzymatic methods or in combination with precipitation procedures. Apolipoproteins were determined by using immunonephelometric methods. ELISA sandwich method was used for lipoprotein(a) determinations. Apoprotein(a) phenotyping (isoforms) was performed by Western blotting with specific antibodies. The concentrations of serum lipids, lipoproteins and apoproteins (AI, AII and B) were found in the range of earlier investigations. The serum lipoprotein(a) concentration did not differ between the PBC patients and control subjects (10.0/0.1- 54/, median 2.55 vs. 11.5/0-75/, median 5.2 mg/dl). In the advanced stages of PBC we found a higher number of patients with low lipoprotein concentration (lower than 1 mg/dl). In patients with shorter durations and milder histological alterations high HDL2 cholesterol subfractions has been detected (stage I = 0.42 ± 0.18, stage II = 0.53 ± 0.29 and stage III = 0.62 ± 0.41 vs. stage IV = 0.26 ± 0.15 mmol/l, P <0.05). Despite the elevation of atherogenic lipoproteins, high HDL2-cholesterol and normal lipoprotein(a) concentrations may be one of the reasons why patients with advanced PBC are not placed at increased risk for atherosclerosis.

AB - We studied a selected group of 39 female patients suffering from primary biliary cirrhosis (PBC). This disease is characterized by typical lipoprotein alterations and elevated concentrations of serum cholesterol. Despite the increased concentration of atherogenic lipoproteins, enhanced atherogenesis is not characteristic of PBC. Serum total cholesterol, triglycerides, HDL2 and HDL3-cholesterol concentrations were measured by enzymatic methods or in combination with precipitation procedures. Apolipoproteins were determined by using immunonephelometric methods. ELISA sandwich method was used for lipoprotein(a) determinations. Apoprotein(a) phenotyping (isoforms) was performed by Western blotting with specific antibodies. The concentrations of serum lipids, lipoproteins and apoproteins (AI, AII and B) were found in the range of earlier investigations. The serum lipoprotein(a) concentration did not differ between the PBC patients and control subjects (10.0/0.1- 54/, median 2.55 vs. 11.5/0-75/, median 5.2 mg/dl). In the advanced stages of PBC we found a higher number of patients with low lipoprotein concentration (lower than 1 mg/dl). In patients with shorter durations and milder histological alterations high HDL2 cholesterol subfractions has been detected (stage I = 0.42 ± 0.18, stage II = 0.53 ± 0.29 and stage III = 0.62 ± 0.41 vs. stage IV = 0.26 ± 0.15 mmol/l, P <0.05). Despite the elevation of atherogenic lipoproteins, high HDL2-cholesterol and normal lipoprotein(a) concentrations may be one of the reasons why patients with advanced PBC are not placed at increased risk for atherosclerosis.

KW - Atherosclerosis

KW - Lipoprotein(a)

KW - Lipoproteins

KW - Primary biliary cirrhosis

UR - http://www.scopus.com/inward/record.url?scp=0030606334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030606334&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(96)06404-2

DO - 10.1016/0009-8981(96)06404-2

M3 - Article

C2 - 8937759

AN - SCOPUS:0030606334

VL - 255

SP - 165

EP - 171

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 2

ER -